{"id":"W2262031814","doi":"10.1371/journal.pone.0147995","title":"A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Erlotinib; Oncology; Internal medicine; Biomarker; Gemcitabine; Pancreatic cancer; Carcinoembryonic antigen; Epidermal growth factor receptor; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002357411,0.0004498254,0.0006817969,0.0005564712,0.0002595442,0.0006037914,0.0004508894,0.0006960665,0.00193867],"category_scores_gemma":[0.003094363,0.0001742525,0.0004080025,0.000638974,0.0001906973,0.0003347049,0.0002734014,0.000596409,0.0005910289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005902799,"about_ca_system_score_gemma":0.000619846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005070553,"about_ca_topic_score_gemma":0.0009691566,"domain_scores_codex":[0.9988415,0.0005173276,0.0001278714,0.0002051018,0.0002213492,0.00008695265],"domain_scores_gemma":[0.9985267,0.0004137445,0.0005454643,0.00009518334,0.0002291654,0.0001897894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1396279,0.003248178,0.6120736,0.0009525401,0.001650506,0.0004167028,0.0002437135,0.003053046,0.070475,0.0003358884,0.01264121,0.1552817],"study_design_scores_gemma":[0.01536601,0.03142577,0.8876917,0.0001231262,0.001605575,0.001572344,0.00008206502,0.006406688,0.03487696,0.0005145859,0.02027539,0.00005968068],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812309,0.003320653,0.00258752,0.0005364163,0.00006145423,0.001982168,0.00676298,0.0001412377,0.003376685],"genre_scores_gemma":[0.9797224,0.0003641981,0.004455076,0.0005012225,0.00005901163,0.00312879,0.0103784,0.00001388188,0.001377022],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002357411,"threshold_uncertainty_score":0.01246732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5859129035741159,"score_gpt":0.4895666324762447,"score_spread":0.09634627109787114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}